anidulafungin has been researched along with tacrolimus in 6 studies
Studies (anidulafungin) | Trials (anidulafungin) | Recent Studies (post-2010) (anidulafungin) | Studies (tacrolimus) | Trials (tacrolimus) | Recent Studies (post-2010) (tacrolimus) |
---|---|---|---|---|---|
568 | 33 | 331 | 17,757 | 2,319 | 6,661 |
Protein | Taxonomy | anidulafungin (IC50) | tacrolimus (IC50) |
---|---|---|---|
Bile salt export pump | Homo sapiens (human) | 7.18 | |
Cytochrome P450 3A4 | Homo sapiens (human) | 0.58 | |
Cytochrome P450 3A5 | Homo sapiens (human) | 0.385 | |
Serine/threonine-protein kinase mTOR | Homo sapiens (human) | 0.0021 | |
Peptidyl-prolyl cis-trans isomerase FKBP1A | Homo sapiens (human) | 0.2547 | |
Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform | Homo sapiens (human) | 0.0148 | |
Splicing factor 3B subunit 3 | Homo sapiens (human) | 0.0123 | |
Broad substrate specificity ATP-binding cassette transporter ABCG2 | Homo sapiens (human) | 3.3 | |
Solute carrier organic anion transporter family member 1B1 | Homo sapiens (human) | 3.7 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (50.00) | 29.6817 |
2010's | 2 (33.33) | 24.3611 |
2020's | 1 (16.67) | 2.80 |
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Alspaugh, JA; Fortwendel, JR; Juvvadi, PR; Perfect, BZ; Perfect, JR; Pinchai, N; Steinbach, WJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Damle, B; Dowell, JA; Henkel, T; Krause, D; Stogniew, M | 1 |
Burhenne, H; Burkhardt, O; Kaever, V; Kielstein, JT | 1 |
Abdorahimi, M; Ahmadikia, K; Badali, H; Gharehbolagh, SA; Khodavaisy, S; Mahmoudi, S; Meis, JF; Rezaie, S | 1 |
1 review(s) available for anidulafungin and tacrolimus
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for anidulafungin and tacrolimus
Article | Year |
---|---|
Lack of pharmacokinetic interaction between anidulafungin and tacrolimus.
Topics: Administration, Oral; Adolescent; Adult; Alanine Transaminase; Anidulafungin; Antifungal Agents; Area Under Curve; Aspartate Aminotransferases; Creatine Kinase; Dizziness; Drug Interactions; Echinocandins; Fatigue; Half-Life; Headache; Humans; Immunosuppressive Agents; Infusions, Intravenous; Male; Middle Aged; Nocturia; Peptides, Cyclic; Tacrolimus; Therapeutic Equivalency; Thrombophlebitis | 2007 |
4 other study(ies) available for anidulafungin and tacrolimus
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Differential effects of inhibiting chitin and 1,3-{beta}-D-glucan synthesis in ras and calcineurin mutants of Aspergillus fumigatus.
Topics: Aminoglycosides; Antifungal Agents; Aspergillus fumigatus; beta-Glucans; Calcineurin; Caspofungin; Cell Wall; Chitin; Echinocandins; Fluorescent Dyes; Fungal Proteins; Genes, Fungal; Genes, ras; Lipopeptides; Microbial Sensitivity Tests; Microscopy, Fluorescence; Mutation; Signal Transduction | 2009 |
Quantitative analysis of the antifungal drug anidulafungin by LC-online SPE-MS/MS in human plasma.
Topics: Anidulafungin; Antifungal Agents; Chromatography, Liquid; Echinocandins; Humans; Reproducibility of Results; Sensitivity and Specificity; Solid Phase Extraction; Tacrolimus; Tandem Mass Spectrometry | 2012 |
In vitro combination of antifungal drugs with tacrolimus (FK506) holds promise against clinical Candida species, including Candida auris.
Topics: Anidulafungin; Animals; Antifungal Agents; Candida; Candida auris; Candida glabrata; Candida parapsilosis; Caspofungin; Echinocandins; Fluconazole; Itraconazole; Microbial Sensitivity Tests; Tacrolimus | 2023 |